DoW Prostate Cancer, Physician Research Award
Closed Posted
- Opportunity number
- HT942526PCRPPRA
- Agency
-
Medical Command
Department of the Army, Department of Defense
- Applications due
- Award size
- Not on record
Opportunity facts
- Assistance listings
- Funding instrument
- Grant
- Category
-
- Science and Technology and other Research and Development
- Eligible applicants
-
- Unrestricted
- Points of contact
-
- eBRAP Help Desk help@ebrap.org (301) 682-5507
Opportunity details come from Grants.gov. Updated .
About this opportunity
The Defense Health Agency is soliciting applications for the FY26 Prostate Cancer Research Program Physician Research Award to support mentored research experiences that prepare early-career physicians for careers in prostate cancer research, with applications due September 2, 2026. The awarding agency anticipates approximately $8.8 million to fund roughly 8 awards with a total cost cap of $1.1 million per award and a maximum period of performance of 4 years (funds expiring September 30, 2032).
Eligible applicants are unrestricted. The PI must be an early-career clinician investigator with clinical duties in the last year of an accredited medical residency or medical fellowship program, or within five years of initiating a faculty appointment. All applications must include at least one mentor who demonstrates established experience in prostate cancer research and successful mentorship, and must include a researcher development plan articulating an individualized strategy for acquiring skills and expertise to complete the project and foster the PI's career development. Clinical trials are not permitted.
All applications must address one of four FY26 PCRP Overarching Challenges: improving health and survivorship for those impacted by prostate cancer; developing new treatments for lethal prostate cancer; enhancing clinical care with special emphasis on high-risk groups; or defining the biology of prostate cancer progression. Required application components include a 10-page project narrative, technical and lay abstracts, statement of work, impact statement, eligibility statement, transition plan, and supporting documentation. Pre-applications are due August 12, 2026 at 5:00 p.m. ET. Peer review is scheduled for November 2026, and programmatic review for March 2027. Award funding is contingent on federal appropriations availability and application quality as assessed through two-tier peer and programmatic review. Extramural organizations submit through Grants.gov; intramural DOW organizations submit through eBRAP. The Assistance Listing is CFDA 12.420 (Military Medical Research and Development).
Synopsis
Summary: The fiscal year 2026 (FY26) Prostate Cancer Research Program (PCRP) Physician Research Award (PRA) Supports a mentored research experience to prepare physicians with clinical duties for careers in prostate cancer research. All applications must address one of the FY26 PCRP Overarching Challenges.
Distinctive Features:
· Early-Career Clinician Investigator: Serves as the Principal Investigator (PI). Includes investigators with clinical duties in the last year of an accredited medical residency or medical fellowship program, or within five years of initiating a faculty appointment.
· Mentorship: Applications must include at least one mentor who demonstrates experience in prostate cancer research and successful mentorship.
· Researcher Development Plan: Applications must include a research development plan articulating an individualized strategy for acquiring necessary skills, competence and expertise to complete the projects and foster the PI's career development.
https://cdmrp.health.mil/pubs/press/2026/pcrppreann
Files
| File | Type | Posted |
|---|---|---|
| HT942526PCRPPRA_GG.pdf |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar grant opportunities
- Ask GovTribe AI about this opportunity